Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Care on the Fly: Telehealth Lands at Bradley Airport
Tech & Innovation Care on the Fly: Telehealth Lands at Bradley Airport

In an era where convenience often dictates the pace of daily life, Bradley International Airport in Windsor Locks, Connecticut, has taken a remarkable step forward by introducing a telehealth kiosk through a partnership between Hartford HealthCare and OnMed. This innovative service, designed to

Unraveling the Mystery of Musical Anhedonia in Neuroscience
Tech & Innovation Unraveling the Mystery of Musical Anhedonia in Neuroscience

Imagine a world where the soaring notes of a symphony or the infectious beat of a pop song evoke nothing—no joy, no emotion, just silence in the soul despite perfect hearing. This is the reality for individuals with specific musical anhedonia, a rare condition where music fails to trigger pleasure,

Advanced Model Predicts Pancreatic Cancer Survival with CT and MRI
Tech & Innovation Advanced Model Predicts Pancreatic Cancer Survival with CT and MRI

Pancreatic cancer remains one of the deadliest forms of cancer, with a disheartening 5-year survival rate lingering around just 12%, largely because it is often diagnosed at advanced stages when treatment options are limited. The scarcity of effective early detection tools worsens this challenge,

Can Congress Improve Veterans’ Access to Non-VA Care?
Research & Development Can Congress Improve Veterans’ Access to Non-VA Care?

Picture a veteran, a Marine Corps and Army hero like John-Paul Sager, sitting in a small-town clinic just miles from home, yet unable to get treatment for chronic pain without wading through a swamp of paperwork and approvals. Across the nation, thousands of veterans face this reality, driving past

How Is Hey Jane Revolutionizing Abortion Access in Michigan?
Tech & Innovation How Is Hey Jane Revolutionizing Abortion Access in Michigan?

In the heart of Michigan, where reproductive health care faces persistent challenges despite legal safeguards, a new player has emerged to address critical gaps in access to abortion services. Hey Jane, a telehealth provider based in New York, has recently extended its reach into the state,

CHMP Recommends Tevimbra for Early-Stage Lung Cancer Care
Management & Regulatory CHMP Recommends Tevimbra for Early-Stage Lung Cancer Care

What if a single drug could redefine survival chances for thousands facing lung cancer surgery in Europe? Imagine a patient, newly diagnosed with non-small cell lung cancer (NSCLC), grappling with the uncertainty of whether their tumor can be removed and if they’ll face recurrence. For many, this

Revolutionary MRI Detects Tiny Cancer Traces in Myeloma Patients
Tech & Innovation Revolutionary MRI Detects Tiny Cancer Traces in Myeloma Patients

In a remarkable stride forward for cancer diagnostics, a cutting-edge whole-body MRI technique is offering new hope to those battling myeloma, a challenging form of blood cancer, through the collaborative efforts of researchers at The Royal Marsden NHS Foundation Trust and The Institute of Cancer

Biogen’s Qalsody Wins UK Approval for Rare ALS Treatment
Management & Regulatory Biogen’s Qalsody Wins UK Approval for Rare ALS Treatment

What happens when a disease as merciless as amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), strikes a tiny fraction of patients with a genetic twist that makes it even deadlier? For the roughly 2% of ALS sufferers with mutations in the SOD1 gene, life has often felt

Persistent SARS-CoV-2 in HIV Patient Sparks Evolution Concerns
Biotech & Bioprocessing Persistent SARS-CoV-2 in HIV Patient Sparks Evolution Concerns

In a remarkable and deeply concerning case that has gripped the attention of medical researchers and public health experts alike, a 41-year-old man with advanced, untreated HIV carried a SARS-CoV-2 infection for an unprecedented 776 days. This extraordinary duration, detailed in a study recently

Two-Drug Combo Boosts Survival in Advanced Kidney Cancer
Research & Development Two-Drug Combo Boosts Survival in Advanced Kidney Cancer

Imagine a diagnosis of advanced kidney cancer, a condition once considered a near-certain death sentence due to limited treatment options, but today, groundbreaking research has shifted this narrative, offering renewed hope to thousands of patients worldwide. The focus of this progress lies in a

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later